| Literature DB >> 34583455 |
Sung Keun Park1, Ju Young Jung1, Chang-Mo Oh2, Min-Ho Kim3, Eunhee Ha4, Yeji Kim5, Do Jin Nam5, Jae-Hong Ryoo6.
Abstract
PURPOSE: There has been accumulating evidence for the preventive effect of high physical activity on cancer. However, it is still unclear which level of physical activity is associated with the decreased risk of pancreatic cancer. The purpose of current study is to assess the association between the frequency of vigorous intensity physical activity and the risk of pancreatic cancer.Entities:
Keywords: Pancreatic neoplasms; Prevention; Vigorous intensity physical activity
Mesh:
Year: 2021 PMID: 34583455 PMCID: PMC9296946 DOI: 10.4143/crt.2021.400
Source DB: PubMed Journal: Cancer Res Treat ISSN: 1598-2998 Impact factor: 5.036
Fig. 1Flow chart of enrolled study subjects.
Baseline characteristics of participants according to the four groups of the physical activity levels (n=220,357)
| Characteristic | Overall | Frequency of high intensity physical activity | ||||
|---|---|---|---|---|---|---|
| Group 1 (n=129,264) | Group 2 (n=66,580) | Group 3 (n=14,122) | Group 4 (n=10,391) | p for trend[ | ||
|
| 965,829.1 | 566,486.9 | 291,642.6 | 61,965.9 | 45,733.7 | |
|
| 4.38±0.45 | 4.38±0.49 | 4.38±0.38 | 4.39±0.37 | 4.40±0.46 | < 0.001 |
|
| 58.1±8.8 | 59.4±9.3 | 55.7±7.5 | 56.7±7.7 | 60.1±8.5 | < 0.001 |
|
| ||||||
| Male | 123,935 (56.2) | 61,919 (47.9) | 46,173 (69.4) | 9,224 (65.3) | 6,619 (63.7) | < 0.001 |
| Female | 96,422 (43.8) | 67,345 (52.1) | 20,407 (30.6) | 4,898 (34.7) | 3,772 (36.3) | |
|
| 24.0±2.9 | 23.9±3.0 | 24.1±2.8 | 24.1±2.7 | 24.1±2.8 | < 0.001 |
|
| 82.0±8.2 | 81.7±8.4 | 82.5±7.9 | 82.1±7.9 | 82.6±7.9 | < 0.001 |
|
| 125.3±15.2 | 125.4±15.5 | 124.9±14.6 | 125.3±14.6 | 126.2±15.1 | < 0.001 |
|
| 77.7±9.9 | 77.5±10.1 | 78.0±9.8 | 77.8±9.8 | 77.9±9.9 | 0.004 |
|
| 200.0±37.5 | 200.3±38.0 | 199.7±36.8 | 199.2±36.5 | 198.5±37.5 | < 0.001 |
|
| 118 (83–170) | 118 (83–170) | 120 (84–174) | 111 (78–162) | 113 (79–163) | < 0.001 |
|
| 55.4±32.5 | 56.0±36.2 | 54.1±25.6 | 55.8±29.0 | 55.7±28.0 | 0.495 |
|
| 118.3±39.0 | 118.6±39.6 | 117.7±37.6 | 117.9±39.3 | 117.3±40.7 | 0.002 |
|
| 100.8±25.4 | 100.5±25.6 | 101.0±25.3 | 101.2±24.2 | 102.0±24.8 | < 0.001 |
|
| 1.15±1.49 | 1.06±1.25 | 1.31±1.83 | 1.26±1.72 | 1.11±1.27 | 0.091 |
|
| 80.6±20.2 | 80.8±19.4 | 80.4±21.7 | 80.2±21.2 | 79.8±18.8 | < 0.001 |
|
| 26.6±16.5 | 26.5±17.1 | 26.7±15.4 | 26.8±14.4 | 27.3±18.2 | < 0.001 |
|
| 25.4±19.4 | 24.9±19.2 | 26.3±19.8 | 25.5±18.9 | 25.1±18.9 | 0.659 |
|
| 39.1±53.9 | 37.5±54.6 | 42.0±52.2 | 39.2±52.4 | 39.6±57.8 | 0.036 |
|
| 7.8±13.9 | 7.1±14.1 | 8.9±13.4 | 8.2±13.2 | 8.1±14.6 | < 0.001 |
|
| 14.3 | 12.4 | 16.4 | 18.2 | 19.4 | < 0.001 |
|
| 377 (0.17) | 244 (0.19) | 107 (0.16) | 16 (0.11) | 10 (0.10) | < 0.001 |
|
| 30.8±10.9 | 30.7±12.2 | 31.4±11.4 | 29.5±9.8 | 27.6±10.3 | < 0.001 |
|
| 874±346 | 817±330 | 932±294 | 1,231±382 | 1,527±419 | < 0.001 |
|
| 7.1±3.4 | 7.2±3.6 | 6.9±3.1 | 7.0±2.9 | 7.1±3.5 | 0.065 |
|
| ||||||
| Number (wk) | 2.8±1.3 | 2.6±1.1 | 2.9±1.4 | 2.4±1.5 | 2.2±1.7 | < 0.001 |
| Minutes | 25.9±8.1 | 27.9±7.5 | 28.6±9.4 | 27.5±10.3 | 25.4±11.2 | < 0.001 |
Values are presented as mean±standard deviation or number (%). Group 1, performing 0 day per week; group 2, performing 1-3 days per week; group 3, performing 4-5 days per week; group 4, performing 6-7 days per week. ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; BP, blood pressure; eGFR, estimated glomerular filtration rate; GGT, γ-glutamyltransferase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MET, metabolic equivalent of task; PA, physical activity; SCr, serum creatinine; WC, waist circumference.
p-value by ANOVA-test for continuous variables and chi-square test for categorical variables.
Comparison between participants with and without incident pancreatic cancer
| Characteristic | Participants without pancreatic cancer (n=219,980) | Participants with pancreatic cancer (n=377) | p-value[ |
|---|---|---|---|
|
| 4.39±0.44 | 2.59±1.24 | < 0.001 |
|
| 58.1±8.8 | 64.8±10.1 | < 0.001 |
|
| |||
| Male | 123,690 (56.2) | 245 (65.0) | < 0.001 |
| Female | 96,290 (43.8) | 132 (35.0) | |
|
| 24.0±2.9 | 23.9±2.8 | 0.803 |
|
| 82.0±8.2 | 83.5±7.8 | < 0.001 |
|
| 125.3±15.2 | 127.7±15.5 | 0.003 |
|
| 77.7±9.9 | 77.7±10.1 | 0.934 |
|
| 200.0±37.5 | 195.1±37.5 | 0.011 |
|
| 141.6±93.8 | 146.8±92.9 | 0.288 |
|
| 55.4±32.5 | 51.0±12.9 | < 0.001 |
|
| 118.3±39.0 | 115.6±37.6 | 0.180 |
|
| 100.8±25.4 | 109.9±35.7 | < 0.001 |
|
| 1.15±1.49 | 1.19±1.55 | 0.615 |
|
| 80.6±20.2 | 75.8±19.3 | < 0.001 |
|
| 26.6±16.4 | 29.3±32.2 | 0.002 |
|
| 25.4±19.3 | 26.0±17.3 | 0.482 |
|
| 39.0±53.8 | 51.6±85.3 | 0.004 |
|
| 7.8±13.9 | 11.6±20.8 | < 0.001 |
|
| 14.3 | 19.1 | 0.009 |
|
| 874±378 | 858±345 | < 0.001 |
|
| 7.1±3.6 | 7.1±3.8 | 0.104 |
|
| |||
| Number (wk) | 2.8±1.4 | 2.3±1.2 | < 0.001 |
| Minutes | 26.0±8.6 | 25.7±9.1 | < 0.001 |
Values are presented as mean±standard deviation or number (%). ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; BP, blood pressure; eGFR, estimated glomerular filtration rate; GGT, γ-glutamyltransferase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MET, metabolic equivalent of task; PA, physical activity; SCr, serum creatinine; WC, waist circumference.
p-value by t-test for continuous variables and chi-square test for categorical variables.
Fig. 2Parameters showing statistically significant difference between group without incident pancreatic cancer (control group) and group with incident pancreatic cancer (pancreatic cancer group). AST, aspartate aminotransferase; eGFR, estimated glomerular filtration rate; GGT, γ-glutamyltransferase; HDL, high-density lipoprotein; WC, waist circumference.
Hazard ratios and 95% confidence intervals for the incidence of pancreatic cancer according to the four groups divided by the frequency of vigorous physical activity
| Person-year | Incidence cases | Incidence density | Hazard ratios (95% confidence interval) | ||
|---|---|---|---|---|---|
| Unadjusted | Adjusted model | ||||
|
| |||||
| Group 1 | 566,486.9 | 244 | 4.3 | 1.00 (reference) | 1.00 (reference) |
| Group 2 | 291,642.6 | 107 | 3.7 | 0.85 (0.68–1.07) | 1.10 (0.86–1.40) |
| Group 3 | 61,965.9 | 16 | 2.6 | 0.60 (0.36–0.99) | 0.75 (0.45–1.25) |
| Group 4 | 45,733.7 | 10 | 2.2 | 0.51 (0.27–0.95) | 0.47 (0.25–0.89) |
| p for trend | 0.014 | 0.004 | |||
|
| - | - | - | - | 1.08 (1.07–1.09) |
|
| - | - | - | - | 0.73 (0.57–0.94) |
|
| - | - | - | - | 1.01 (0.97–1.04) |
|
| - | - | - | - | 1.000 (0.992–1.006) |
|
| - | - | - | - | 1.007 (1.004–1.009) |
|
| - | - | - | - | 1.000 (0.997–1.003) |
|
| - | - | - | - | 0.998 (0.993–1.003) |
|
| - | - | - | - | 1.002 (1.000–1.003) |
|
| - | - | - | - | 1.009 (1.003–1.015) |
|
| - | - | - | - | 1.124 (0.844–1.497) |
Incidence density: number of incident pancreatic cancer per 10,000 person-year. Adjusted model: multivariate adjustment for age, sex, BMI, systolic BP, fasting blood glucose, LDL-cholesterol, eGFR, GGT, smoking amount (pack-year), and alcohol intake. Group 1, performing 0 day per week; group 2, performing 1-3 days per week; group 3, performing 4-5 days per week; group 4, performing 6-7 days per week. BMI, body mass index; BP, blood pressure; eGFR, estimated glomerular filtration rate; GGT, γ-glutamyltransferase; LDL, lowdensity lipoprotein.